Neurological Narratives: A Journey into Women’s Brain Health Research

FHS
March 7, 2024
12:17 pm

This insightful interview explores the disparities in neurological care and the innovative strategies aimed at transforming research and treatment for better, inclusive health outcomes.

Donanemab may offer new hope for people with early Alzheimer’s disease

The data reported today by Eli Lilly from the TRAILBLAZER-ALZ 2 clinical trial of donanemab in early symptomatic Alzheimer’s disease demonstrate an important advancement in

July 17, 2023

Researchers identify new therapeutic for patients with a rare autoimmune disease EGPA

An international team, including researchers from McMaster University and St. Joseph’s Healthcare Hamilton, has identified a new therapeutic for patients with a rare autoimmune disease

February 24, 2024

Lykos cuts team by 75%, vows to keep MDMA program despite FDA veto

Lykos will be culling 75% of its workforce as it continues to work on the MDMA therapy. Image credit: Getty Images / mathisworks Lykos Therapeutics

August 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.